FREE Stock Screener<\/a><\/p>\n Don\u2019t forget to check out our FREE Large Cap 1000 \u2013\u00a0Stock Screener<\/a>, here at\u00a0The Acquirer\u2019s Multiple:<\/p>\n
\n
<\/p>\n
As part of our ongoing series at The Acquirer\u2019s Multiple, each week we highlight a stock from our Stock Screeners that may represent an undervalued opportunity hiding in plain sight.<\/p>\n
This week\u2019s spotlight is Nutex Health Inc. (NUTX) \u2014 a healthcare services and technology company focused on micro-hospitals, hospital operations, and population health management solutions across the United States.<\/p>\n
Despite investor concerns around healthcare reimbursement pressure, execution risk, and the company\u2019s rapid expansion strategy, NUTX currently trades at valuation levels that may suggest the market is underestimating the improvement in its operating performance, cash generation, and scalability.<\/p>\n
Business Overview<\/p>\n
Nutex Health operates a hybrid healthcare model combining facility operations with cloud-based population health management technology. The company focuses on smaller, localized healthcare facilities designed to provide emergency and outpatient care more efficiently than traditional large hospital systems.<\/p>\n
Core components of the business include:<\/p>\n
\u2713 Micro-hospitals
\u2713 Emergency healthcare services
\u2713 Population health management
\u2713 Cloud-based healthcare platforms
\u2713 Hospital operational partnerships<\/p>\n
The business benefits from growing healthcare demand, localized facility networks, and recurring patient engagement across its operating footprint.<\/p>\n
What Is IV\/P?<\/p>\n
IV\/P compares a conservative intrinsic valuation to the current market price.<\/p>\n
IV\/P > 1 = Undervalued
IV\/P < 1 = Overvalued<\/p>\n
NUTX\u2019s IV\/P = 1.70, suggesting the stock may be trading below conservative intrinsic value estimates.<\/p>\n
Supporting Metrics<\/p>\n
Revenue (TTM): $880M
Gross Profit: $418M
Operating Income: $276M
Net Income: $96M
Free Cash Flow: $269M<\/p>\n
Acquirer\u2019s Multiple (AM): 4.32<\/p>\n
An AM near 4 places NUTX in deep value territory, particularly for a business that has recently demonstrated substantial operating leverage and improving profitability.<\/p>\n
Revenue & Profitability<\/p>\n
Recent financial results reflect dramatic improvement in operating performance as revenue growth and margin expansion accelerated.<\/p>\n
Approximate margins:<\/p>\n
\u2022 Gross Margin: 47%
\u2022 Operating Margin: 31%
\u2022 Net Margin: 11%<\/p>\n
Diluted EPS (TTM): $13.67<\/p>\n
These margins reflect:<\/p>\n
\u2022 Rapid scaling of operations
\u2022 Improved healthcare facility utilization
\u2022 Higher-margin technology services
\u2022 Operating leverage
\u2022 Strong reimbursement collections<\/p>\n
Unlike many speculative healthcare growth stories, Nutex is now producing meaningful operating income and free cash flow alongside expanding revenues.<\/p>\n
Balance Sheet Position<\/p>\n
Total Assets: $919M
Total Liabilities: $495M
Shareholders\u2019 Equity: $423M
Total Debt: $351M
Cash & Equivalents: $186M<\/p>\n
The balance sheet has strengthened considerably alongside rising profitability and cash generation.<\/p>\n
Working Capital: $381M<\/p>\n
This provides flexibility for expansion, debt management, and continued investment in healthcare infrastructure.<\/p>\n
Cash Flow & Capital Efficiency<\/p>\n
Operating Cash Flow: $273M
Free Cash Flow: $269M<\/p>\n
This supports:<\/p>\n
\u2713 Expansion opportunities
\u2713 Debt management
\u2713 Share repurchases
\u2713 Operational investment
\u2713 Financial flexibility<\/p>\n
Because capital expenditure requirements remain relatively modest compared to cash generation, a large portion of earnings converts directly into free cash flow.<\/p>\n
Why NUTX May Be Attractive<\/p>\n
Market concerns include:<\/p>\n
\u2022 Healthcare reimbursement uncertainty
\u2022 Regulatory risk
\u2022 Execution risk
\u2022 Volatile historical results
\u2022 Small-cap healthcare sentiment<\/p>\n
However, fundamentals remain compelling:<\/p>\n
\u2022 AM of 4.32 signals deep value
\u2022 IV\/P of 1.70 suggests undervaluation
\u2022 Rapid revenue growth
\u2022 Strong operating leverage
\u2022 Significant free cash flow generation
\u2022 Improving balance sheet<\/p>\n
Conclusion<\/p>\n
With an IV\/P of 1.70 and an Acquirer\u2019s Multiple of 4.32, Nutex Health appears to be an intriguing deep-value opportunity in healthcare.<\/p>\n
Its combination of rapidly improving profitability, strong cash generation, scalable healthcare infrastructure, and discounted valuation suggests the market may still be heavily discounting past uncertainty while underappreciating the company\u2019s current earnings power and operational momentum.<\/p>\n
For all the latest news and podcasts, join our free newsletter here<\/a>.<\/p>\n FREE Stock Screener<\/a><\/p>\n Don\u2019t forget to check out our FREE Large Cap 1000 \u2013\u00a0Stock Screener<\/a>, here at\u00a0The Acquirer\u2019s Multiple:<\/p>\n
![\"unlimited\"](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2025\/10\/unlimited.jpg\"\/)
<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"
As part of our ongoing series at The Acquirer\u2019s Multiple, each week we highlight a stock…\n","protected":false},"author":2,"featured_media":208798,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[49,48,84,392],"class_list":["post-691641","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-ca","tag-canada","tag-health","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/691641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=691641"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/691641\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/208798"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=691641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=691641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=691641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}